News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,037 Results
Type
Article (7931)
Company Profile (34)
Press Release (137072)
Multimedia
Podcasts (3)
Webinars (2)
Section
Business (43488)
Career Advice (239)
Deals (5205)
Drug Delivery (15)
Drug Development (21225)
Employer Resources (35)
FDA (2585)
Job Trends (3622)
News (72002)
Policy (5207)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Genetown Standard (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 Pharm Country Standard (1)
Academia (915)
Accelerated approval (1)
Adcomms (3)
Allergies (23)
Alliances (12043)
ALS (29)
Alzheimer's disease (548)
Antibody-drug conjugate (ADC) (24)
Approvals (2587)
Artificial intelligence (72)
Autoimmune disease (5)
Automation (5)
Bankruptcy (31)
Best Places to Work (3200)
BIOSECURE Act (1)
Biosimilars (19)
Biotechnology (23)
Bladder cancer (23)
Brain cancer (8)
Breast cancer (96)
Cancer (625)
Cardiovascular disease (72)
Career advice (223)
Career pathing (8)
CAR-T (41)
Cell therapy (108)
Cervical cancer (2)
Clinical research (16595)
Collaboration (237)
Compensation (33)
Complete response letters (3)
COVID-19 (698)
CRISPR (18)
C-suite (96)
Cystic fibrosis (37)
Data (763)
Denatured (1)
Depression (12)
Diabetes (64)
Diagnostics (1545)
Digital health (2)
Diversity, equity & inclusion (9)
Drug discovery (35)
Drug pricing (9)
Drug shortages (3)
Duchenne muscular dystrophy (32)
Earnings (11081)
Editorial (7)
Employer branding (7)
Employer resources (33)
Events (22516)
Executive appointments (239)
FDA (2852)
Featured Employer (13)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (235)
Gene editing (38)
Generative AI (8)
Gene therapy (80)
GLP-1 (174)
Government (914)
Guidances (13)
Healthcare (3869)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (22)
Indications (9)
Infectious disease (733)
Inflammatory bowel disease (45)
Influenza (11)
Intellectual property (22)
Interviews (34)
IPO (2036)
IRA (5)
Job creations (623)
Job search strategy (201)
Kidney cancer (2)
Labor market (7)
Layoffs (88)
Leadership (5)
Legal (881)
Liver cancer (14)
Lung cancer (81)
Lymphoma (38)
Machine learning (2)
Management (11)
Manufacturing (54)
MASH (22)
Medical device (1796)
Medtech (1798)
Mergers & acquisitions (3288)
Metabolic disorders (171)
Multiple sclerosis (20)
NASH (5)
Neurodegenerative disease (28)
Neuropsychiatric disorders (8)
Neuroscience (711)
NextGen: Class of 2025 (1273)
Non-profit (1395)
Northern California (618)
Now hiring (6)
Obesity (86)
Opinion (49)
Ovarian cancer (12)
Pain (17)
Pancreatic cancer (18)
Parkinson's disease (54)
Partnered (5)
Patents (44)
Patient recruitment (27)
Peanut (9)
People (18102)
Pharmaceutical (7)
Phase I (4946)
Phase II (7011)
Phase III (5811)
Pipeline (303)
Policy (24)
Postmarket research (663)
Preclinical (3204)
Press Release (33)
Prostate cancer (28)
Psychedelics (11)
Radiopharmaceuticals (48)
Rare diseases (108)
Real estate (1217)
Recruiting (15)
Regulatory (3884)
Reports (8)
Research institute (1024)
Resumes & cover letters (23)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (18)
Series A (59)
Series B (17)
Sickle cell disease (24)
Southern California (498)
Special edition (1)
Spinal muscular atrophy (66)
Sponsored (14)
Startups (1180)
State (1)
Stomach cancer (3)
Supply chain (9)
Tariffs (2)
The Weekly (2)
United States (5524)
Vaccines (135)
Venture capitalists (8)
Weight loss (37)
Women's health (7)
Worklife (2)
Date
Today (46)
Last 7 days (162)
Last 30 days (688)
Last 365 days (8282)
2025 (2391)
2024 (8869)
2023 (10131)
2022 (12898)
2021 (14119)
2020 (12484)
2019 (10036)
2018 (7699)
2017 (7858)
2016 (7578)
2015 (8161)
2014 (5961)
2013 (4756)
2012 (4881)
2011 (5147)
2010 (4330)
Location
Africa (162)
Alabama (12)
Alaska (4)
Arizona (32)
Arkansas (2)
Asia (7966)
Australia (1353)
California (1362)
Canada (515)
China (102)
Colorado (70)
Connecticut (69)
Delaware (32)
Europe (22011)
Florida (159)
Georgia (48)
Idaho (9)
Illinois (99)
India (2)
Indiana (54)
Iowa (2)
Japan (39)
Kansas (11)
Kentucky (4)
Louisiana (3)
Maine (38)
Maryland (169)
Massachusetts (1248)
Michigan (75)
Minnesota (61)
Missouri (21)
Montana (5)
Nebraska (6)
Nevada (12)
New Hampshire (14)
New Jersey (386)
New Mexico (21)
New York (508)
North Carolina (216)
North Dakota (2)
Northern California (618)
Ohio (67)
Oklahoma (6)
Oregon (19)
Pennsylvania (323)
Puerto Rico (2)
Rhode Island (13)
South America (196)
South Carolina (2)
Southern California (498)
Tennessee (19)
Texas (229)
Utah (65)
Virginia (32)
Washington D.C. (8)
Washington State (137)
Wisconsin (12)
145,037 Results for "semler scientific".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Semler Scientific® Reports First Quarter 2024 Financial Results
Semler Scientific, Inc. reported financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
9 min read
Business
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
Semler Scientific, Inc. today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial market.
April 23, 2024
·
2 min read
Business
Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
Semler Scientific, Inc., a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, reported financial results for the fourth quarter and full year ended December 31, 2023.
March 5, 2024
·
11 min read
Biotech Bay
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
Semler Scientific, Inc. today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023, after the close on Tuesday, March 5, 2024.
February 21, 2024
·
2 min read
Business
Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors
- Semler Scientific, Inc. announced that Eric Semler and William H.C. Chang, who collectively beneficially own more than 20% of Semler Scientific’s outstanding shares, will immediately join Semler Scientific’s board of directors as new independent directors.
April 19, 2023
·
8 min read
Biotech Bay
Semler Scientific to Present at Upcoming September 2023 Investor Conference
Semler Scientific, Inc., a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, announced Renae Cormier, CFO, will participate in the following investor conference.
August 31, 2023
·
1 min read
Biotech Bay
Semler Scientific to Join the Russell 2000® and 3000® Indexes
Semler Scientific, Inc. announced that it is set to join the Russell 2000® and 3000® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023.
June 23, 2023
·
3 min read
Business
Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results
Semler Scientific, Inc., a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, reported financial results for the three and six months ended June 30, 2023.
August 10, 2023
·
10 min read
Business
Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
Semler Scientific, Inc. today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining.
July 11, 2023
·
5 min read
Business
Semler Scientific Reports First Quarter 2023 Financial Results
Semler Scientific, Inc., a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, reported financial results for the three months ended March 31, 2023.
May 10, 2023
·
9 min read
1 of 14,504
Next
